Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $15.70B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $7.68B in assets. In the last trailing year, the best performing Biotech ETF was the BBC at 50.48%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

Top ETF Performers

CHNA Loncar China BioPharma ETF 8.30%
BBC Virtus LifeSci Biotech Clinical Trials ETF 3.59%
PBE Invesco Dynamic Biotechnology & Genome ETF 2.28%
UBIO ProShares UltraPro Nasdaq Biotechnology 1.02%
BIB ProShares Ultra NASDAQ Biotechnology 1.00%

Bottom ETF Performers

ZBIO ProShares UltraPro Short Nasdaq Biotechnology -2.89%
LABU Direxion Daily S&P Biotech Bull 3X Shares -2.18%
BIS ProShares UltraShort Nasdaq Biotechnology -1.55%
BBH VanEck Vectors Biotech ETF -0.30%
LABD Direxion Daily S&P Biotech Bear 3X Shares -0.30%

Top Creations

LABD Direxion Daily S&P Biotech Bear 3X Shares 67.87
BBC Virtus LifeSci Biotech Clinical Trials ETF 7.53
PBE Invesco Dynamic Biotechnology & Genome ETF 2.34
BIS ProShares UltraShort Nasdaq Biotechnology 1.96
GNOM Global X Genomics & Biotechnology ETF 1.60

Top Redemptions

IBB iShares NASDAQ Biotechnology ETF -545.18
LABU Direxion Daily S&P Biotech Bull 3X Shares -75.12
BIB ProShares Ultra NASDAQ Biotechnology -15.51
FBT First Trust NYSE Arca Biotechnology Index Fund -15.08
BBH VanEck Vectors Biotech ETF -7.17

AUM Winners

CHNA Loncar China BioPharma ETF 15.16%
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 10.67%
BIS ProShares UltraShort Nasdaq Biotechnology 10.45%
XBI SPDR S&P Biotech ETF 8.84%
GNOM Global X Genomics & Biotechnology ETF 4.82%

AUM Losers

BBP Virtus LifeSci Biotech Products ETF -17.97%
LABD Direxion Daily S&P Biotech Bear 3X Shares -14.23%
LABU Direxion Daily S&P Biotech Bull 3X Shares -10.41%
BIB ProShares Ultra NASDAQ Biotechnology -7.03%
CNCR Loncar Cancer Immunotherapy ETF -3.71%

ETF Report

Sectors In Review: January 2020

Sector ETFs had a great month, with most seeing positive returns.

ETF Report

 Sectors In Review: December 2019

A few sector ETFs faltered during the month

ETF Report

 Sectors In Review: November 2019

Sector ETFs did fairly well during the month, with a few exceptions

ETF Report

Sectors In Review: September 2019

Sector ETFs recorded largely positive performance during July.

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

ETF Report

Smart Beta: Beyond The Hype

Despite all the buzz, advisors have reasons to be wary of such strategies.

Features and News

Politics Weigh On Health Care ETFs

Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?

Daily ETF Watch

ETF Week: Zero-Fee Funds Debut

Plus, the first space ETF rolls out.